18 歳未満の青少年におけるニコチン使用の治療: 公式のアメリカ胸部協会の臨床実践ガイドライン
American journal of respiratory and critical care medicine
|August 29, 2025
まとめ
このガイドラインは,青年のニコチン使用の治療のための証拠に基づいた勧告を提供し,若者の間で電子タバコの使用の増加に対処しています. 若者の喫煙傾向を逆転させ,ニコチン依存症と闘うことを目的としています.
科学分野:
- 青少年 の 健康
- 公衆衛生
- ニコチン依存症 の 治療
背景:
- 電子タバコ (e-cigarette) の使用は,青少年の間で最も一般的なニコチン製品であり,青少年の喫煙減少の進展を逆転させている.
- 青少年の電子タバコの使用は 将来の喫煙とニコチン依存の増大と関連しています
- 小児科のガイドラインでは 10歳からタバコ使用のスクリーニングを推奨しています
研究 の 目的:
- 10歳から18歳の若者のニコチン使用の治療のための証拠に基づいた臨床実践ガイドラインを策定する.
- 青少年におけるニコチン使用の管理を担当する医療従事者に 実行可能な勧告を提供すること.
主な方法:
- 5つのPICO (患者,介入,比較器,結果) 問題を扱う証拠の統合
- 証拠の確実性を評価するために,推奨,評価,開発,評価の格付け (GRADE) のアプローチを使用した.
- 専門家パネルのコンセンサスと証拠の評価に基づく勧告を策定する.
主要な成果:
- パネルは,様々な治療方法の証拠の強さと臨床的利益を評価した.
- 合成された証拠の全体的な質は弱いと判断された.
- 青少年のニコチン使用に対する特定の治療方法の賛成または反対の勧告が策定された.
結論:
- このガイドラインは,青少年におけるニコチン使用の治療について,専門家の推薦に基づくものです.
- 推奨事項は,若者のニコチン製品使用の問題に対処する臨床医を支援することを目的としています.
さらに関連する動画
06:12Using Nicotine in a Silica-Exposed Mouse Model to Promote Lung Epithelial-Mesenchymal Transition
Published on: March 3, 2023
885
09:30A Microcontroller Operated Device for the Generation of Liquid Extracts from Conventional Cigarette Smoke and Electronic Cigarette Aerosol
Published on: January 18, 2018
8.5K
関連する概念動画
Drugs Acting on Autonomic Ganglia: Stimulants
1.5K
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
1.5K
Asthma-IV: Nursing Management
3.3K
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
First, in...
3.3K
Stimulants
311
Stimulants are substances that enhance neural activity and elevate dopamine levels in the brain, leading to their highly addictive nature. These drugs include cocaine, amphetamines, MDMA, caffeine, and nicotine, each with distinct mechanisms of action and varied health implications.
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
311
Asthma-IV: Diagnostic and Management
2.6K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.6K
CNS Depressants: Alcohol and Nicotine
358
Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
358
Chronic Obstructive Pulmonary Disease-V: Management
2.7K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.7K
